SMART Personalized Chemotherapy

Despite progress in the treatment of tumors, resistance to chemotherapy drugs and inter-individual differences in sensitivity to drug treatment remain a substantial obstacle to the healing of many patients. TICheP project aims to develop an innovative technological framework for the development of a personalized chemotherapy allowing reduced toxicity treatment. It will use ovarian carcinoma as a model, but it has the potential for extension to other types of tumors.

Technology

The project proposes the development of a microfluidic in-flux totally automated system for the execution of pharmacological sensitivity tests to be performed on peritoneal carcinosis cells taken from a patient. The automated tests evaluate the individual response to chemotherapeutic drugs.

News

Tichep project co-financing remakable results!

Check out on this article https://www.nature.com/articles/s41388-020-01433-6 Oncogene is a peer-reviewed scientific journal published by the Nature Publishing Group addressing cancer cell genetics and the structure and function of oncogenes. The journal aims to make substantial advances in our knowledge of processes that contribute to cancer by publishing outstanding research. A new important scientific discovery in …

TiCHEP at Meet in Italy for Life Science

Meet TiCHEP Smart Personalized Therapy :16 octobre, 13.30-14.30 Auditorium atMeet in Italy for Life Sciences 2019 event, Trieste, Magazzino Molo IV workshop title: Progetti collaborativi pubblico-privati di Ricerca e Innovazione finanziati dal programma POR-FESR 2014-2020 in FVG Description (Italian) : verranno presentati alcuni esempi di progetti di Ricerca e Innovazione collaborativi tra le imprese, le …